SENSEX NIFTY

Glaxosmithkline

Sep 20, 2016 at 13:32 | Source: Reuters
Walmsley, who joined Britain's biggest drugmaker in 2010 from LOreal, will replace Andrew Witty who had previously announced his decision to retire on March 31, 2017.
Sep 19, 2016 at 12:02 | Source: PTI
"Suresh has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer. Over the years, he has played multiple leadership roles in Business Development, Marketing, Sales and Strategy," the company said in a statement.
Sep 15, 2016 at 19:49 | Source: Moneycontrol.com
Some investors shy away from buying stocks that have high prices. The belief is unfounded.
Sep 12, 2016 at 14:10 | Source: Reuters
The two firms, which have a long history of working together, said on Monday that Aspen would pay 180 million pounds for the products Ultiva, Nimbex, Tracrium, Mivacron and Anectinein, plus up to 100 million pounds in milestone payments.
Sep 12, 2016 at 10:22 | Source: PTI
The tie up between the drug maker and Verily, the health subsidiary of Google's parent company Alphabet, will focus on treatments for people living with the chronic disease.
Sep 01, 2016 at 08:01 | Source: CNBC-TV18
ACC | Ambuja Cement | India Cements | IOC | MCX | Ramco Cements | UltraTech Cement | Jaiprakash Associates | JK Cements | Tata Power | KEC International | Uniply Industries | C&C Constructions | Praj Industries | Esab India and Indo Rama Synthetics are stocks, which are in the news today.
Aug 31, 2016 at 12:40 | Source: CNBC-TV18
GSK had tried to sell the land parcel in 2014. But the deal fell through because of legal hurdles. Piramal Realty and K Raheja were frontrunners to buy the plot in 2014.
Aug 30, 2016 at 10:55 | Source: Moneycontrol.com
Be prepared. India is likely to see positive confidence shock with consumer discretionary and retail financiers to be benefitting the most. According to Abhay Laijawala of Deutsche Bank Multiple 7th Pay Commission, good monsoon, low interest rates and easing liquidity should provide a significant boost to aggregate demand in second half of FY17.
Aug 30, 2016 at 07:38 | Source: CNBC-TV18
Potential stock beneficiaries include Bajaj Finserv, GSK Consumer, Hero Motocorp, LIC Housing Finance, Titan Company and Whirlpool India, Abhay Laijawala of Deutsche Bank feels.
Aug 19, 2016 at 10:30 | Source: PTI
The second annual 'Change the World' list is topped by UK's GlaxoSmithkline, followed by Israel-based IDE Technologies and American conglomerate General Electric at the second and third positions, respectively.
Messages on Glaxosmithkline »

mumbai_mark
et

New Member

0 Follower

GlaxoSmithKline  

glaxosmithkline said on tuesday it had chosen emma walmsley, head of consumer healthcare, as its new chief executive, after considering internal and external candidates.

11.20 AM Sep 21st

gurubhaiind
ia001

New Member

0 Follower

GlaxoSmithKline  

glaxosmithkline picks insider emma walmsley as new ceo

11.19 AM Sep 21st

arvind151

Platinum Member

77687 Followers

GlaxoSmith Con  

GlaxoSmithKline Consumer Healthcare- close below 6000 trend wil be bearish !!!

6.11 PM Sep 20th

BSE/NSE Announcer

Platinum Member

17384 Followers

GlaxoSmith Con  

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Companys Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from September 15, 2016 and shall end 24 hours after declaration of Audited / Unaudited Financial

6.02 PM Sep 12th

BSE/NSE Announcer

Platinum Member

17384 Followers

GlaxoSmith Con  

GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that in accordance with the Companys Policy on Insider Trading, the date of commencement of closing of "Trading Window" shall be from September 15, 2016 and shall end 24 hours after declaration of Audited / Unaudited Financial Results

6.01 PM Sep 12th

BSE/NSE Announcer

Platinum Member

17384 Followers

GlaxoSmithKline  

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".

3.58 PM Sep 12th

kaams

New Member

0 Follower

GlaxoSmithKline  

Good results expected plus the land sale windfall of about 1700 cr. - My target for GlaxoSmithKline is Rs 3800 for the short term with a stoploss of Rs 3600

3.38 PM Sep 1st

BSE/NSE Announcer

Platinum Member

17384 Followers

GlaxoSmithKline  

The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 31, 2016 with reference to news flashed on CNBC TV18 dated August 31, 2016 stating "GSK Pharma invites bid for 60 acre land parcel in Thane, valued at 1400-1800 Cr"The reply is awaited.

12.41 PM Aug 31st

BSE/NSE Announcer

Platinum Member

17384 Followers

GlaxoSmith Con  

GlaxoSmithkline Consumer Healthcare Ltd has submitted to BSE a copy of minutes of 57th Annual General Meeting (AGM) of the Company held on August 05, 2016.

5.34 PM Aug 30th

BSE/NSE Announcer

Platinum Member

17384 Followers

GlaxoSmith Con  

GlaxoSmithKline Pte Ltd along with Horlicks and GlaxoSmithKline plc made an open offer to the shareholders of the GlaxoSmithkline Consumer Healthcare.

12.07 PM Feb 7th 2013

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.